Stock-Based Compensation Expense (Tables)

3 Months Ended

Mar. 31, 2026

Stock-Based Compensation Expense [Abstract]

Schedule of Stock Options Vested and Exercisable

The following table summarizes information about the Company’s stock options outstanding as well as stock options vested and exercisable as of March 31, 2026, and activity during the three month period then ended:

						Weighted-
						average
				Weighted-		remaining
				average		contractual		Aggregate
				exercise		term		intrinsic
	Shares			price		(years)		value
Outstanding as of December 31, 2025		924		$	13,475.78		4.41	$	‒
Granted		459,031			2				‒
Exercised		‒			‒				‒
Cancelled/forfeited		(92	)	$	17,075.07				‒
Outstanding as of March 31, 2026		459,863		$	25.73		9.97	$	‒
Vested and expected to vest at March 31, 2026		459,863		$	25.73		9.97	$	‒
Vested and exercisable at March 31, 2026		726		$	12,893.30		4.23	$	‒

Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values

The following weighted average assumptions were used in estimating the grant date fair values on March 31, 2026 and 2025: 

	March 31,
	2026			2025
Fair value of common stock	$	1.29		$	-
Expected term (in years)		5.27			-
Risk-free rate		4.05	%		3.94	%
Expected volatility		69.98	%		53.60	%
Dividend yield		0	%		0	%